ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of an Oxidized Regenerated Cellulose After Thyroid Surgery: A Prospective, Randomized Study (ORC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01171079
Recruitment Status : Completed
First Posted : July 28, 2010
Last Update Posted : July 28, 2010
Sponsor:
Information provided by:
Seoul National University Hospital

Brief Summary:
The purpose of this study is to evaluate the effects and safety of oxidized, regenerated cellulose as an absorbable adhesion barrier after thyroidectomy.

Condition or disease Intervention/treatment Phase
Thyroidectomy Device: application of oxidized regenerated cellulose Not Applicable

Study Type : Interventional  (Clinical Trial)
Official Title: Use of an Oxidized Regenerated Cellulose After Thyroid Surgery: A Prospective, Randomized Study

Arm Intervention/treatment
Experimental: Interceed Device: application of oxidized regenerated cellulose




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • operable thyroid neoplasm

Exclusion Criteria:

  • a history of previous neck surgeries or uncontrolled medical diseases such as hyperthyroidism, diabetes, and hypertension
  • administration of non-steroidal anti-inflammatory drugs (NSAIDs) or anti-platelet agents within 1 week before surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01171079


Locations
Korea, Republic of
Seoul National University College of Medicine
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital